Modulight Spotlights: LASER-SHARP RESEARCH – April 2023
Metastases remain the leading cause of cancer-related deaths worldwide. To combat this problem, Ruben V. Huis in ‘t Veld et al. combined immune checkpoint inhibitors with a light-activated virus-drug conjugate in their preclinical study. As published in Cancer Immunology, Immunotherapy journal, the combination was effective against metastatic tumors and in most cases even resulted in complete responses to therapy.
Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!
#LaserSharpResearch #photoimmunotherapy #immunotherapy #combinationtherapy
Modulight products used:
ML6600 – High-power laser system with multi-wavelength support
Illumination kit for in vitro and in vivo research (MLAKIT)
Read more:
In-vitro and in-vivo illumination »
About Modulight’s LASER-SHARP RESEARCH concept:
Modulight has launched a concept where our scientific board highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.
Contact Us
Do you have questions or comments related to this LASER-SHARP RESEARCH nomination? Maybe your group has done significant research that your would like us to spotlight? Or would you like to request literature? Please drop us a line!